During this interview with Kate Quirke, we explore the challenges of moving into a new market, while focusing on growth and expansion in the healthcare industry. Hear more about Kate’s strategy for Alcidion, the company’s initial challenges, and now their plans for growth over the next year.
- Following Alcidion’s acquisition of MKM Health in 2018, the company focused on accelerating growth across Australia, New Zealand, and UK geographies via organic investment and targeted M&A activity
- To facilitate the M&A activity, Alcidion partnered with Henslow and in 2021 completed two acquisitions – ExtraMed and Silverlink – both serving to expand product capability, customer penetration whilst delivering increased financial strength
- Driven by the impacts of Covid, Alcidion has seen increased interest in their modular EPR solutions focused on Virtual Care (treating patients at home) and the flow of patients through the hospital
- Providing solutions for several large ANZ hospital customers, along with holding a 27% market penetration within acute NHS Trusts in the UK, Alcidion is well placed to become a leading global healthcare company
“We have a lot of strong females in our business, we’re in the healthcare business. By the very nature of healthcare being a strong female profession, we ought to be able to attract more women into our leadership roles.”